Viewing Study NCT02051751


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-01-19 @ 3:47 PM
Study NCT ID: NCT02051751
Status: COMPLETED
Last Update Posted: 2020-12-08
First Post: 2014-01-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Potential Benefit of the Addition of BYL719 to Paclitaxel in the Treatment of Breast Cancer and Head-and-neck Cancer
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module